Hbm Holdings Ltd HBMHF:OTCPK

RT Quote | Exchange | USD
Last | 04/13/22 EDT
0.482UNCH (UNCH)
52 week range
0.48 - 0.48
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.482
  • 52 Week High0.48
  • 52 Week High Date04/13/22
  • 52 Week Low0.48
  • 52 Week Low Date03/24/22

Key Stats

  • Market Cap299.51M
  • Shares Out745.29M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.482
  • 52 Week High0.48
  • 52 Week High Date04/13/22
  • 52 Week Low0.48
  • 52 Week Low Date03/24/22
  • Market Cap299.51M
  • Shares Out745.29M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.19
  • P/E (TTM)-2.56
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hbm Holdings Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
HBM Holdings Ltd is an investment holding company mainly engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. The Company’s products include batoclimab, mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD); and tanfanercept, mainly used for dry eye disease (DED). In addition, the Company researches and develops...
Address
Hong Kong